Clinical Trials Directory

Trials / Conditions / Idiopathic Inflammatory Myopathy

Idiopathic Inflammatory Myopathy

8 registered clinical trials studyying Idiopathic Inflammatory Myopathy — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in A
NCT07085104
Allogene TherapeuticsPhase 1
Enrolling By InvitationA Study of KITE-363 in Participants With Refractory Autoimmune Diseases
NCT07038447
Kite, A Gilead CompanyPhase 1
RecruitingRESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Id
NCT06154252
Cabaletta BioPhase 2 / Phase 3
RecruitingA Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Dise
NCT05869955
Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyPhase 1
CompletedMuscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties
NCT05027152
Federal University of Espirito SantoN/A
UnknownClinical Study of MMF in Treatment of IIM-ILD and Its Effect on Peripheral Blood Treg Cells
NCT05129410
First Affiliated Hospital Xi'an Jiaotong UniversityPhase 4
Active Not RecruitingMYOPROSP - a Prospective Cohort Study in Myositis
NCT02468895
University of Manchester—
CompletedA Case-control Study to Assess Risk of Coronary Heart Disease in Idiopathic Inflammatory Myopathy
NCT00971828
Northern Care Alliance NHS Foundation Trust—